Wave Life Sciences Taps Shire Finance Exec as CFO
Cambridge, MA-based RNA drug developer Wave Life Sciences (NASDAQ: WVE) has named Keith Regnante its chief financial officer. Regnante was previously the VP of finance at Shire, and had stints at Biogen and Boston Consulting Group before that.
More from EXOME
Trending on Xconomy
Underwriters and Partners
Xpertise: Watch + Learn
Xconomy Insight · Special Report
Starting a Biotech Company: What Every Entrepreneur Needs to Know
Get advice from the experts to help your biotech startup succeed